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Table. Demographics and clinical characteristics
Variables
VAA
PObserved Repaired
Splenic
Patients, No. (%) 53 (47.3) 59 (52.7)
Age, mean 6 SD, years 66.8 6 13.3 54.3 6 15.6 <.0001
Females, No. (%) 41 (77.4) 33 (55.9) .017
Smoking, No. (%) 12 (23.5) 21 (36.2) .151
Diabetes, No. (%) 8 (15.7) 8 (13.6) .752
CRI, No. (%) 4 (7.8) 7 (11.9) .54
ESRD, No. (%) 1 (1.9) 1 (1.7) .999
HTN, No. (%) 35 (8.6) 29 (49.2) .039
HLD, No. (%) 15 (29.4) 17 (28.8) .945
CAD, No. (%) 5 (9.8) 7 (12.1) .767
COPD, No. (%) 0 (0) 6 (10.2) .999
CVA/TIA, No. (%) 2 (3.9) 1 (1.7) .596
Size, mean 6 SD mm 14.5 6 7.2 27.76 18.2 <.0001
Renal
Patients, No. (%) 11 (28.9) 27 (71.1)
Age, mean 6 SD years 60.7 6 16.2 52.6 6 16.5 .172
Females, No. (%) 9 (81.8) 20 (74.1) .611
Smoking, No. (%) 1 (9.1) 4 (14.81) .999
DM, No. (%) 0 (0.0) 2 (7.4) .999
CRI, No. (%) 1 (9.1) 0 (0.0) .289
ESRD, No. (%) 0 (0.0) 2 (7.4) .999
HTN, No. (%) 7 (63.6) 19 (70.4) .685
HLD, No. (%) 3 (27.3) 7 (26.9) .999
CAD, No. (%) 0 (0.0) 3 (11.1) .542
COPD, No. (%) 2 (7.4) 2 (7.4) .999
CVA/TIA, No. (%) 0 (0.0) 0 (0.0)
Size, mean 6 SD mm 14.7 6 8.4 22.3 6 7.9 .014
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease; CRI, chronic renal insufﬁciency; CVA/TIA, cerebrovascular acci-
dent/transient ischemic attack; DM, diabetes mellitus; ESRD, end-stage
renal disease; HLD, hyperlipidemia; HTN, hypertension; SD, standard
deviation; VAA, visceral artery aneurysms.
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Volume 60, Number 3 Abstracts 835and Associates Inc, Flagstaff, Ariz) is an expanded polytetraﬂuoroethylene
(ePTFE) graft with an external nitinol stent on one end, designed for
remote venous implantation with high axillary dialysis access creation. We
recently used this device to treat femoral anastomotic disruptions in two
postoperative patients.
Methods: A 51-year-old woman presented with a massive groin he-
matoma and external bleeding on day 7 after a common femoral to
below-knee popliteal bypass with an in situ great saphenous vein graft.
She had no prior signs of infection. At exploration, dehiscence of the vein
graft was noted but no other evidence of infection. We deployed the stent
end of the graft into the external iliac artery through the femoral defect, and
anastomosed the graft end to the in situ graft and profunda femoris artery
distal to the dehiscence. The second patient was a 90-year-old man with
enlarging femoral artery anastomotic aneurysm after having undergone
prior endovascular exclusion. His comorbidities included severe aortic valve
stenosis and renal failure. Under tumescent anesthesia, we performed a right
groin exploration and discovered a 7-cm anastomotic aneurysm with local-
ized rupture and inﬂammatory changes extending into the iliac fossa. There
was no deﬁnite evidence of infection. We deployed the stent end of the Gore
Hybrid graft into the external iliac artery over an inﬂated balloon catheter
and extended proximally for persistent bleeding around the graft with a
10-mm  100-mm Viabahn (W.L. Gore and Associates). The ePTFE graft
was then anastomosed to the vein graft. Intraoperative gram stains were
negative in both patients, and sartorius muscle ﬂap closure was used.
Results: Both wounds healed and the grafts remain patent without
infection, now 6 and 3 months out from surgery, respectively.
Conclusions: The hybrid device offers an excellent off-the-shelf alter-
native for deﬁnitive treatment for anastomotic dehiscence while avoiding an
abdominal incision. It may also serve as bridge therapy in the setting of
infection to maintain distal perfusion until a suitable autogenous or extra-
anatomic revascularization can be achieved.
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Clinical Correlation of Anatomical Location of Nonthrombotic Iliac
Vein Lesion>
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Ganelin. Total Vascular Care, Brooklyn, NY
Objective: Nonthrombotic iliac vein lesions are an active area of
research. The advantages of intravascular ultrasound (IVUS) imaging
include allowing the exact localization of these lesions. We chose to use
IVUS to explore the anatomical location of nonthrombotic iliac vein lesions
(NIVLs) and correlate it with clinical ﬁndings.
Methods: Over the course of 7 months, we performed 217 iliofe-
moral IVUS-assisted studies in 141 women and 76 men. The average 6
standard deviation age of examined population was 68 6 14 years (range,
22-96 years). We used IVUS intraoperatively to measure and record the
area of the involved iliofemoral veins. The measurement of stenosis was
compared with the adjacent nonstenotic iliofemoral veins. If >50% cross-
sectional area or diameter reduction was found by IVUS imaging, it was
treated with appropriate balloon size (range 10  40 to 16  60) and stent
(12-to 24-mm diameter  40-to 90-mm length). We used the Boston Sci-
entiﬁc Mobile Cart System IVUS to perform these measurements.
Results: We identiﬁed 233 lesions: 115 in left lower extremity (LLE)
and 118 in the right lower extremity (RLE). The CEAP scores in the LLE
were C1: 0; C2: 35; C3: 40; C4: 15; C5: 20; and C6: 6; with the most common
site being the proximal common iliac vein in 37.4% (20.86% females and 16.5%
males). The CEAP scores in the RLE were C1: 0; C2: 31; C3: 42; C4: 14; C5:
23; and C6: 7; and the most common site was in the middle external iliac vein
in 31.35% (20.4% females and 11.01% males). The least common site of the
NIVL in the LLE was in the distal external iliac vein in 2.6% (2.6% females
and 0% males). In the RLE, the least common site of NIVL was also in the
distal external vein 7.62% (5.93% females and 1.69% males). No correlation be-
tween age, laterality, gender, or CEAP score were noted.
Conclusions: This analysis gives an insight into understanding the
anatomical location of the NIVL, which is often an undiagnosed cause of
lower extremity venous diseases. Despite multiple questions yet to be
answered, the results give an insight to clinicians and researches to guide
their treatment and research.
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Objectives: Visceral artery aneurysms (VAA) are rare, with poorly char-
acterized natural history and treatment outcomes. We reviewed the long-term
outcomes of conservative management of splenic and renal aneurysms.
Methods: A retrospective review of patients with conservatively
managed or treated VAA from 2000 to 2013 was conducted. Characteristics
and outcomes were compared.
Results: We identiﬁed 150 patients with VAA: 64 were conservatively
managed and 86 underwent open or endovascular repair. Demographics,
comorbidities, anatomy, and presentation are detailed in the Table. The
mean follow-up for observed VAA was 37.5 6 42.1 months, and 53 splenic
and 11 renal aneurysms were followed up for a mean of 34.6 6 40.3
months. Splenic aneurysms ranged in diameter from 7.7 to 45.9 mm,
with 56.6% being at the hilum, and 81.1% were heavily calciﬁed speciﬁcally
in the observed group. Most patients were women beyond the childbearing
age. Renal aneurysms ranged in diameter from 6.3 to 30.2 mm and were
primarily localized to the proximal renal artery (54.5%). Most patients
were older females. During the follow-up period, the mean diameter of
splenic and renal aneurysms remained unchanged. No patients in the
observed group required an intervention for elective or urgent repair. No
aneurysm-related mortality was identiﬁed in the observed group for both
renal and splenic aneurysms
Conclusions: Splenic and renal aneurysms can be conservatively
managed even at a diameter >15 mm, especially in older patients and post-
menopausal women. The growth rate in patients aged >65 years is very
slow, and rupture or need for elective repair are rare over long-term follow-up.>Eastern Vascular Society
Fig. Magnetic resonance angiography of pelvic vasculature, demonstrating
the absence of the inferior vena cava (IVC).
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Objectives: This article describes the presentation and management
of two vascular compressive syndromes occurring within the same patient.
Median arcuate ligament syndrome (MALS) presents as chronic mesenteric
ischemia secondary to compression of the celiac trunk by the median arcuate
ligament. Treatment by surgical decompression can provide relief.
Nutcracker syndrome presents as vague ﬂank or pelvic pain along with
hematuria. It occurs secondary to compression of the left renal vein
(LRV) by the superior mesenteric artery (SMA). Transposition of the
LRV has been described to manage symptoms. Rarely do these two
compressive syndromes occur simultaneously.
Methods: A 33-year-old man presented with chronic abdominal/
ﬂank pain, nausea/vomiting, and hematuria. Physical examination,
biochemical analysis, and endoscopic and ﬂuoroscopic evaluations did not
reveal an etiology. Contrasted computed tomography revealed extrinsic
compression of the celiac trunk consistent with MALS. In addition, the
presence of LRV compression (with poststenotic dilatation) by the SMA
was consistent with nutcracker syndrome.
Results: The patient underwent simultaneous open release of the MAL
along with LRV transposition. His postoperative course was unremarkable.
The patient reported a marked improvement in his abdominal symptoms.
Conclusions: Vascular compressive syndromes, such as MAL and
nutcracker syndromes, occur infrequently. Surgical intervention can provide
symptomatic relief in properly selected patients.
Disclosures: S. Iranmanesh: Nothing to disclose; B. W. Howell: Nothing
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Objectives: Pulmonary embolectomy can be lifesaving for massive
and submassive pulmonary embolisms (PEs). Recurrent PE after surgery
has devastating consequences. Inferior vena caval (IVC) ﬁlters can be placed
intraoperatively to minimize the interval during which the patient may be
vulnerable to re-embolization. We report our experience with routine trans-
atrial ﬁlter placement during pulmonary embolectomy.
Methods: Between April 2009 and September 2013, 18 consecutive
patients (11 women) with a mean age of 59.3 years (range, 28-84 years) un-
derwent pulmonary embolectomy for massive and submassive PE (8 and 10
patients, respectively). Six patients (33%) presented with cardiogenic shock
or arrest. The most common PE risk factors were deep vein thrombosis (13
patients [72%]), immobility (7 patients [39%]), and malignancy (6 patients
[33%]). Embolectomy was performed on cardiopulmonary bypass with sys-
temic hypothermia. During the rewarming period, a purse-string suture was
placed in the right atrial appendage, and ﬂuoroscopic guidance was used to
pass a ﬁlter through the atrium into the IVC.
Results: Mean length of stay was 14 days (range, 6-44 days). Mean
follow-up was 22 months (range, 1-56 months). Technical success was
100%. There were no perioperative deaths or recurrent PEs in our patients.
Four patients required transfusions, and respiratory failure developed in two
patients. One late death was caused by metastatic malignancy.
Conclusions: Patients with massive and submassive PE may undergo
pulmonary embolectomy with minimal risk for recurrent PE and death with
routine intraoperative IVC ﬁlter placement. Further investigation is needed to
better deﬁne the role of transatrial IVC ﬁlters in the surgical management of PE.
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Objectives: We report a case of a 16-year-old male patient with
infrarenal IVC agenesis and venous collateralization, symptomatic with
venous stasis ulceration.
Methods: An extensive literature search was performed using MED-
LINE and PubMed databases using search terms: congenital, agenesis, vena
cava, infrarenal inferior vena cava, magnetic resonance venogram, venous stasis
ulcers. Articles regarding case reports of agenesis of the vena cava were found,
with no mention of venous stasis ulceration as the primary symptomatology.
Results: The patient initially presented with venous stasis dermatitis and
ulceration in the medial malleolar region bilaterally. Duplex imaging revealed
absence of the infrarenal IVC and iliofemoral venous system.Magnetic resonance
venography was then performed, which conﬁrmed the above ﬁndings (Fig),
along with revealing extensive lumbar and pelvic collateralization and the pres-
ence of a large retroaortic left renal vein. This patient’s condition has been suc-
cessfully managed conservatively with compression therapy and wound care.
Conclusions: This case is an example of a rare congenital malformation
of the infrarenal vena cava and represents the only reported case with present-
ing symptoms of venous stasis ulceration. This is likely an example of an under
diagnosed condition due to its nonpathognomonic symptoms and broad
range of differential diagnoses. More commonly, this condition presents in
the setting of thromboembolism as reported in available case reports
currently in literature. Conservative compression therapy appears to be the
treatment of choice for this particular symptom in this rare malformation.Disclosures: J. Phair: Nothing to disclose; E. Trestman:Nothing to disclose;
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